Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/1/1995
1.
Phase II Study of Ipomeanol for Hepatocellular Carcinoma (Summary Last Modified 08/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 18
NCI
JHOC-92082005
NCI-T92-0174C, T92-0174
Last Modified:
2/1/1990
2.
Phase I Study of 4-Ipomeanol in Patients with Advanced Lung Cancer (Summary Last Modified 02/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 18
NCI
JHOC-87102702
NCI-T87-0292C, T87-0292
Last Modified:
7/1/1995
3.
Phase I Study of 4-Ipomeanol for Advanced Nonsmall Cell Carcinoma of the Lung (Summary Last Modified 07/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
NCI-88-C-0122B
NCI-NMOB-882, NCI-T88-0079N, T88-0079
Last Modified:
11/1/1990
4.
Phase I Investigation of Ipomeanol in Patients with Refractory Lung Cancer (Summary Last Modified 11/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
over 18
NCI
OSU-88HO310
NCI-T88-0225C, T88-0225
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute